Hans-Ulrich Kreider-Stempfle, Thomas Remp, Sibylle Puntscher, Uwe Siebert, Norah Kreider
{"title":"Comparison of endovascular infrapopliteal revascularisation strategies based on the angiosome model in diabetics with CLTI.","authors":"Hans-Ulrich Kreider-Stempfle, Thomas Remp, Sibylle Puntscher, Uwe Siebert, Norah Kreider","doi":"10.1024/0301-1526/a001153","DOIUrl":null,"url":null,"abstract":"<p><p><b></b> <i>Background:</i> Infrapopliteal endovascular interventions (EVT) strategies in diabetic patients are still in debate because the lesions are more likely to be diffuse with a different pattern of collateral arteries ranging from reduced to normal caliber. The aim of this all-comers study was to analyse the outcome of two different infrapopliteal EVT strategies (Group I: angiosome-based direct revascularization - DR vs. Group II: complete (direct + indirect) revascularization strategy - CR) in diabetic patients with chronic limb-threatening ischemia (CLTI) in 2 time-periods. Furthermore we analysed the outcome if DR or CR failed and only indirect revascularization (IR) or no revascularization was possible. Both groups were differentiated in patients with collaterals, defined as an intact pedal arch (immediate or after pedal PTA). <i>Patients and methods:</i> The database includes 91 consecutive EVT with two intrapopliteal interventional strategies performed in 68 diabetic patients (pts. 24 female, 44 male, mean age 73±10 years) between 2013-2016 and 2017-2022. Positive clinical outcome was defined as wound healing with or w/o minor amputation, combined with a symptom improvement to Rutherford category 0 or 1 after 6 months. The clinical outcome proportions were compared using the Fisher's exact test. <i>Results:</i> Successful DR (59%) and successful CR (47%) strategy demonstrated a similar positive clinical outcome (92.6% vs. 90.5%; <i>p</i>=0.594). Indirect revascularization (Group I: 26%; Group II: 44%) showed a significantly lower positive outcome in comparison to a successful DR as well as CR strategy (33.3% vs. 92.6%, <i>p</i>=0.0003; 40% vs 90.5%, <i>p</i>=0.001). IR outcome improved by the presence of collaterals (66.7% vs. 30.8%). <i>Conclusions:</i> In case of successful intervention, both strategies (DR and CR) yielded a similarly high proportion of positive clinical outcome. The role of collaterals and the pedal arch on the clinical outcome are important in patients in whom only IR was possible.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":"27-34"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vasa-european Journal of Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1024/0301-1526/a001153","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Infrapopliteal endovascular interventions (EVT) strategies in diabetic patients are still in debate because the lesions are more likely to be diffuse with a different pattern of collateral arteries ranging from reduced to normal caliber. The aim of this all-comers study was to analyse the outcome of two different infrapopliteal EVT strategies (Group I: angiosome-based direct revascularization - DR vs. Group II: complete (direct + indirect) revascularization strategy - CR) in diabetic patients with chronic limb-threatening ischemia (CLTI) in 2 time-periods. Furthermore we analysed the outcome if DR or CR failed and only indirect revascularization (IR) or no revascularization was possible. Both groups were differentiated in patients with collaterals, defined as an intact pedal arch (immediate or after pedal PTA). Patients and methods: The database includes 91 consecutive EVT with two intrapopliteal interventional strategies performed in 68 diabetic patients (pts. 24 female, 44 male, mean age 73±10 years) between 2013-2016 and 2017-2022. Positive clinical outcome was defined as wound healing with or w/o minor amputation, combined with a symptom improvement to Rutherford category 0 or 1 after 6 months. The clinical outcome proportions were compared using the Fisher's exact test. Results: Successful DR (59%) and successful CR (47%) strategy demonstrated a similar positive clinical outcome (92.6% vs. 90.5%; p=0.594). Indirect revascularization (Group I: 26%; Group II: 44%) showed a significantly lower positive outcome in comparison to a successful DR as well as CR strategy (33.3% vs. 92.6%, p=0.0003; 40% vs 90.5%, p=0.001). IR outcome improved by the presence of collaterals (66.7% vs. 30.8%). Conclusions: In case of successful intervention, both strategies (DR and CR) yielded a similarly high proportion of positive clinical outcome. The role of collaterals and the pedal arch on the clinical outcome are important in patients in whom only IR was possible.
背景:糖尿病患者的髂腹下血管内介入治疗(EVT)策略仍存在争议,因为病变更有可能是弥漫性的,侧支动脉的形态也不尽相同,有的直径缩小,有的直径正常。本研究的目的是分析两种不同的腘窝下EVT策略(第一组:基于血管造影剂的直接血管再通--DR与第二组:完全(直接+间接)血管再通策略--CR)在两个时间段内对患有慢性肢体缺血(CLTI)的糖尿病患者的治疗效果。此外,我们还分析了如果 DR 或 CR 失败,只能进行间接血管再通(IR)或无法进行血管再通的结果。两组患者均有肢体侧支,即完整的足弓(立即或在足弓 PTA 后)。患者和方法:数据库包括2013-2016年和2017-2022年期间为68名糖尿病患者(患者24名女性,44名男性,平均年龄(73±10)岁)实施的91例连续EVT,采用两种髂内介入策略。阳性临床结果定义为伤口愈合,伴有或不伴有轻微截肢,6个月后症状改善至卢瑟福0类或1类。临床结果比例的比较采用费雪精确检验。结果如下DR成功率(59%)和CR成功率(47%)显示出相似的积极临床结果(92.6% vs. 90.5%;P=0.594)。与成功的 DR 和 CR 策略相比,间接血运重建(第一组:26%;第二组:44%)的阳性结果明显较低(33.3% vs. 92.6%,p=0.0003;40% vs. 90.5%,p=0.001)。红外预后因存在侧支而有所改善(66.7% 对 30.8%)。结论在干预成功的情况下,两种策略(DR 和 CR)都能产生类似高比例的积极临床结果。对于只能进行 IR 治疗的患者,瓣膜和足弓对临床结果的影响非常重要。
期刊介绍:
Vasa is the European journal of vascular medicine. It is the official organ of the German, Swiss, and Slovenian Societies of Angiology.
The journal publishes original research articles, case reports and reviews on vascular biology, epidemiology, prevention, diagnosis, medical treatment and interventions for diseases of the arterial circulation, in the field of phlebology and lymphology including the microcirculation, except the cardiac circulation.
Vasa combines basic science with clinical medicine making it relevant to all physicians interested in the whole vascular field.